SUMMARY Serum creatine kinase, myoglobin, and percentage lymphocyte capping was determined in ten patients with Duchenne muscular dystrophy, 12 carriers (nine definite and three probable), 16 other female relatives, and eight normal controls. There was no detectable difference in lymphocyte capping ability between any of these clinical groups. Significant myoglobinaemia was present in all the affected males, but the difference in levels between carriers and controls suggested that this test has no advantage over creatine kinase estimations in carrier detection.
Despite recent reports of membrane abnormalities in patients with Duchenne muscular dystrophy (DMD),1-4 estimation of serum creatine kinase (SCK) has remained the most popular and, so far, the most reliable means of carrier identification.5 However, this test is far from ideal and not all definite carriers have raised levels. Even with early investigation of those at risk6 only 70 to 75% of carriers have abnormal values. There was considerable interest, therefore, in reports by Verrill et Sixteen female relatives other than those described above were listed as possible carriers.
There were eight normal controls, who were unrelated fathers of affected children. The serum myoglobin levels in fig 3 show a very clear difference between patients and the other groups in most cases. In nine males with the disease the median was 750 ng/ml with a range of 152 to 920 ng/ml. In eight definite carriers the median was 46 ng/ml and the range 35 to 840 ng/ml. Twelve possible carriers had a range of 15 to 42 ng/ml and a median of 27*5 ng/ml, whereas in eight controls the median was 26.5 ng/ml with a range of 14 to 48 ng/mI.
Methods
Although the median in definite carriers was higher than in controls, there was considerable overlapping of results. Five of their myoglobin levels were lower than the highest of the controls, and six fell within our normal range.
SCK concentrations are shown in fig 4. All of the affected males showed markedly raised levels. None of the definite carriers had concentrations within the normal range, although the increases were much smaller than in the affected group. Neither of the two with raised myoglobin levels had normal SCK values.
In Adornato and his colleagues11 measured myoglobin concentrations by a complement fixation technique which is less sensitive than the radioimmunoassay method used in the Nottingham series. This would account for the division of subjects into those with and those without myoglobinaemia, whereas we have been able to measure the lower levels of myoglobin normally present in the serum. We did not include the forearm ischaemic exercise test in these preliminary investigations. There does appear to be considerable day to day fluctuation in myoglobin levels, a fact commented upon by Adornato et al, and confirmation of some diurnal variation has been noted in our laboratory. Adornato et al also list a number of conditions in which myoglobinaemia may be found but none of these were present in our patients. SCK levels were single specimen estimations only although it is usual practice to take an average of three values. Despite this, this test seemed to be more helpful than myoglobin estimation.
Neither of these newly described investigations appears to allow better discrimination between
